Skip to main content
. 2018 Mar 2;8(2):147–164. doi: 10.1016/j.apsb.2018.01.013

Figure 1.

Fig. 1

Rise in FDA-approved BLAs for therapeutic biologics over the past decade. The past decade has seen a significant rise in the number of FDA-approved BLAs, and therapeutic biologics are becoming a larger percent of the total FDA-approvals (NME and BLA). The data were obtained directly from www.fda.gov (last accessed January 3, 2018).